Revvity Signals Software: Accelerating Scientific Breakthroughs
Enterprise software solutions that help scientists make smarter decisions to develop more effective products and treatments to enable life-changing scientific breakthroughs.
Our complex world is moving at an extraordinary pace and it’s not enough that scientists react to it, but they must anticipate the impact of our environment on people’s lives every day with revolutionary breakthroughs, scientific discoveries, and life-changing therapies.
That’s where Signals Software comes in.
Our modern software solutions, developed with decades of experience, accelerate research and development, and facilitate innovation.
Signals Software was originally founded as CambridgeSoft in 1998 and was acquired by Revvity, Inc. in 2011 to advance the company’s vision for accelerating scientific discoveries. And though the company gained much of its notoriety from its products, it’s our people who make the biggest difference.
Our scientists are arguably the best collection of scientific thought-leaders in the world. A company known for its unparalleled legacy and experience in both hardware and software, our software solutions like ChemDraw® have galvanized scientists the world over for the last quarter century, enabling some of the more impactful and famous scientific discoveries the world has ever known.
Today, Signals Software operates in the United States, Canada, Europe and Asia and employs more than 500 employees, serving more than 10 million end-users worldwide.
With a mission focused on innovating for a healthier world, we deliver unique solutions to serve the diagnostics, life sciences, food, and applied markets. We strategically partner with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise.
Signals Software is a division of Revvity, Inc. a dedicated team of about 14,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $3.8 billion in 2020, serves customers in 190 countries, and is a component of the S&P 500 index.
Additional information is available at the Revvity website.